
One Weight-Loss Drug Slowed Alzheimer’s, Two Didn’t. That’s Good News.
Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.



























